Dr. Wiernik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Hennepin County Medical Center Revenue Management
701 Park Ave South
Minneapolis, MN 55415Phone+1 612-873-3044Fax+1 612-630-8242
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2010 - 2013
- Hennepin County Medical Examiner2007 - 2010
- Universidad de Ciencias MedicasClass of 2006
Certifications & Licensure
- MN State Medical License 2013 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 44 citationsSuccessful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resectionWaseem Touma, Spencer Hoostal, Richard A. Peterson, Andres Wiernik, Karen S. SantaCruz
Journal of Clinical Neuroscience. 2017-07-01 - 168 citationsTargeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibitionAndres Wiernik, Bree Foley, Bin Zhang, Michael R. Verneris, Erica D. Warlick
Clinical Cancer Research. 2013-07-15 - 187 citationsCD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.Michelle K. Gleason, Julie A. Ross, Erica D. Warlick, Troy C. Lund, Michael R. Verneris
Blood. 2014-05-08
Research History
- Research FellowUniversity of Minnesota
- Research FellowKarolinska Institute, Stockholm, Sweden
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: